{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:27:02Z","timestamp":1793158022603,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Guangzhou Key Research and Development Program of Guangzhou Science and Technology Plan Foundation","award":["2023B03J0529"],"award-info":[{"award-number":["2023B03J0529"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82371996"],"award-info":[{"award-number":["82371996"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82402332"],"award-info":[{"award-number":["82402332"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82460356"],"award-info":[{"award-number":["82460356"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the National Key Research and Development Program","award":["2022YFC2403803"],"award-info":[{"award-number":["2022YFC2403803"]}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515010072"],"award-info":[{"award-number":["2022A1515010072"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Laboratory Project of Guangdong Provincial Department of Education for Ordinary Universities","award":["2024KSYS018"],"award-info":[{"award-number":["2024KSYS018"]}]},{"DOI":"10.13039\/501100019314","name":"Guangdong Province Key Laboratory for Green Processing of Natural Products and Product Safety","doi-asserted-by":"publisher","award":["2021ZDB02"],"award-info":[{"award-number":["2021ZDB02"]}],"id":[{"id":"10.13039\/501100019314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012547","name":"Natural Science Foundation of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["2025GXNSFHA069001"],"award-info":[{"award-number":["2025GXNSFHA069001"]}],"id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00259-025-07474-x","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T23:44:22Z","timestamp":1756511062000},"page":"1532-1548","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Synthesis, preclinical evaluation, and clinical translation of [68Ga]Ga-Asp2-JR11, a SSTR2 antagonist for PET imaging of neuroendocrine neoplasms"],"prefix":"10.1007","volume":"53","author":[{"given":"Zihao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhisheng","family":"Jie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadeer","family":"Tudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingze","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixia","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganghua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,30]]},"reference":[{"key":"7474_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41571-022-00696-0","volume":"20","author":"K Kawasaki","year":"2023","unstructured":"Kawasaki K, Rekhtman N, Quintanal-Villalonga \u00c1, Rudin CM. Neuroendocrine neoplasms of the lung and gastrointestinal system: convergent biology and a path to better therapies. Nat Rev Clin Oncol. 2023;20:16\u201332.","journal-title":"Nat Rev Clin Oncol"},{"key":"7474_CR2","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.neo.2017.09.002","volume":"19","author":"B Oronsky","year":"2017","unstructured":"Oronsky B, Ma PC, Morgensztern D, Carter CA. Nothing but NET: a review of neuroendocrine tumors and carcinomas. Neoplasia. 2017;19:991\u20131002.","journal-title":"Neoplasia"},{"key":"7474_CR3","first-page":"35","volume":"11","author":"XB Zhang","year":"2024","unstructured":"Zhang XB, Fan YB, Jing R, et al. Gastroenteropancreatic neuroendocrine neoplasms: current development, challenges, and clinical perspectives. Mil Med Res. 2024;11:35.","journal-title":"Mil Med Res"},{"key":"7474_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.811209","volume":"12","author":"G Hou","year":"2022","unstructured":"Hou G, Zhang Y, Liu Y, et al. Head-to-head comparison of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET\/CT in patients with tumor-induced osteomalacia: a prospective study. Front Oncol. 2022;12: 811209.","journal-title":"Front Oncol"},{"key":"7474_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9121810","volume":"9","author":"MI Del Olmo-Garcia","year":"2021","unstructured":"Del Olmo-Garcia MI, Prado-Wohlwend S, Andres A, Soriano JM, Bello P, Merino-Torres JF. Somatostatin and somatostatin receptors: from signaling to clinical applications in neuroendocrine neoplasms. Biomedicines. 2021;9: 1810.","journal-title":"Biomedicines"},{"key":"7474_CR6","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s00259-012-2330-6","volume":"40","author":"L Bodei","year":"2013","unstructured":"Bodei L, Mueller-Brand J, Baum RP, et al. The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2013;40:800\u201316.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7474_CR7","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1200\/JCO.2015.64.0987","volume":"34","author":"SM Sadowski","year":"2016","unstructured":"Sadowski SM, Neychev V, Millo C, et al. Prospective study of 68Ga-DOTATATE positron emission tomography\/computed tomography for detecting gastro-entero-pancreatic neuroendocrine tumors and unknown primary sites. J Clin Oncol. 2016;34:588\u201396.","journal-title":"J Clin Oncol"},{"key":"7474_CR8","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1097\/RLU.0000000000003188","volume":"45","author":"A Sharma","year":"2020","unstructured":"Sharma A, Das CJ, Makharia GK, Arora G, Kumar R. Comparison of contrast-enhanced CT\u2009+\u2009CT enterography and 68Ga-DOTANOC PET\/CT in gastroenteropancreatic neuroendocrine tumors. Clin Nucl Med. 2020;45:848\u201353.","journal-title":"Clin Nucl Med"},{"key":"7474_CR9","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1148\/rg.352140164","volume":"35","author":"MS Hofman","year":"2015","unstructured":"Hofman MS, Lau WF, Hicks RJ. Somatostatin receptor imaging with 68Ga DOTATATE PET\/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation. Radiographics. 2015;35:500\u201316.","journal-title":"Radiographics"},{"key":"7474_CR10","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.7150\/thno.96762","volume":"14","author":"G Hou","year":"2024","unstructured":"Hou G, Cheng X, Yang Y, et al. Diagnostic performance and clinical impact of 18F-AlF-NOTA-octreotide in a large cohort of patients with neuroendocrine neoplasms: a prospective single-center study. Theranostics. 2024;14:3213\u201320.","journal-title":"Theranostics"},{"key":"7474_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.7150\/thno.88619","volume":"14","author":"RP Baum","year":"2024","unstructured":"Baum RP, Wang P, Jakobsson V, et al. Peptide receptor radionuclide therapy (PRRT) in metastatic neuroendocrine tumors of unknown primary (CUP-NETs). Theranostics. 2024;14:133\u201342.","journal-title":"Theranostics"},{"key":"7474_CR12","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.annonc.2020.03.304","volume":"31","author":"M Pavel","year":"2020","unstructured":"Pavel M, \u00d6berg K, Falconi M, et al. Gastroenteropancreatic neuroendocrine neoplasms: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31:844\u201360.","journal-title":"Ann Oncol"},{"key":"7474_CR13","doi-asserted-by":"publisher","first-page":"16436","DOI":"10.1073\/pnas.0607761103","volume":"103","author":"M Ginj","year":"2006","unstructured":"Ginj M, Zhang H, Waser B, et al. Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors. Proc Natl Acad Sci U S A. 2006;103:16436\u201341.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7474_CR14","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1007\/s00259-024-06639-4","volume":"51","author":"M Liu","year":"2024","unstructured":"Liu M, Cheng Y, Bai C, et al. Gallium-68 labeled somatostatin receptor antagonist PET\/CT in over 500 patients with neuroendocrine neoplasms: experience from a single center in China. Eur J Nucl Med Mol Imaging. 2024;51:2002\u201311.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7474_CR15","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.2967\/jnumed.114.138834","volume":"55","author":"D Wild","year":"2014","unstructured":"Wild D, Fani M, Fischer R, et al. Comparison of somatostatin receptor agonist and antagonist for peptide receptor radionuclide therapy: a pilot study. J Nucl Med. 2014;55:1248\u201352.","journal-title":"J Nucl Med"},{"key":"7474_CR16","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.2967\/jnumed.120.253096","volume":"62","author":"W Zhu","year":"2021","unstructured":"Zhu W, Cheng Y, Jia R, et al. A prospective, randomized, double-blind study to evaluate the safety, biodistribution, and dosimetry of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in patients with well-differentiated neuroendocrine tumors. J Nucl Med. 2021;62:1398\u2013405.","journal-title":"J Nucl Med"},{"key":"7474_CR17","doi-asserted-by":"publisher","first-page":"897","DOI":"10.2967\/jnumed.119.235093","volume":"61","author":"W Zhu","year":"2020","unstructured":"Zhu W, Cheng Y, Wang X, et al. Head-to-head comparison of 68Ga-DOTA-JR11 and 68Ga-DOTATATE PET\/CT in patients with metastatic, well-differentiated neuroendocrine tumors: a prospective study. J Nucl Med. 2020;61:897\u2013903.","journal-title":"J Nucl Med"},{"key":"7474_CR18","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s00259-024-06978-2","volume":"52","author":"H Liang","year":"2025","unstructured":"Liang H, Chen Z, Mo C, Han Y, Liu Q, Tang G. Synthesis and preclinical evaluation of [18F]AlF-NOTA-Asp2-PEG2-JR11 as a novel antagonist radioligand for PET imaging of somatostatin receptor. Eur J Nucl Med Mol Imaging. 2025;52:1189\u201399.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7474_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107352","volume":"147","author":"C Mo","year":"2024","unstructured":"Mo C, Sun P, Liang H, et al. Synthesis and preclinical evaluation of a novel probe [18F]AlF-NOTA-IPB-GPC3P for PET imaging of GPC3 positive tumor. Bioorg Chem. 2024;147: 107352.","journal-title":"Bioorg Chem"},{"key":"7474_CR20","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.2967\/jnumed.116.186783","volume":"58","author":"M Fani","year":"2017","unstructured":"Fani M, Nicolas GP, Wild D. Somatostatin receptor antagonists for imaging and therapy. J Nucl Med. 2017;58:S61-6.","journal-title":"J Nucl Med"},{"key":"7474_CR21","doi-asserted-by":"publisher","first-page":"17785","DOI":"10.1021\/acs.jmedchem.4c01812","volume":"67","author":"J Huang","year":"2024","unstructured":"Huang J, Zhang X, Liu Q, et al. 68Ga\/177Lu-labeled theranostic pair for targeting fibroblast activation protein with improved tumor uptake and retention. J Med Chem. 2024;67:17785\u201395.","journal-title":"J Med Chem"},{"key":"7474_CR22","doi-asserted-by":"publisher","first-page":"909","DOI":"10.2967\/jnumed.117.199737","volume":"59","author":"GP Nicolas","year":"2018","unstructured":"Nicolas GP, Beykan S, Bouterfa H, et al. Safety, biodistribution, and radiation dosimetry of 68Ga-OPS202 in patients with gastroenteropancreatic neuroendocrine tumors: a prospective phase I imaging study. J Nucl Med. 2018;59:909\u201314.","journal-title":"J Nucl Med"},{"key":"7474_CR23","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1007\/s00259-023-06282-5","volume":"50","author":"J Huang","year":"2023","unstructured":"Huang J, Fu L, Zhang X, et al. Noninvasive imaging of FAP expression using positron emission tomography: a comparative evaluation of a [18F]-labeled glycopeptide-containing FAPI with [18F]FAPI-42. Eur J Nucl Med Mol Imaging. 2023;50:3363\u201374.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7474_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2967\/jnumed.119.229229","volume":"61","author":"M Sathekge","year":"2020","unstructured":"Sathekge M, Bruchertseifer F, Vorster M, et al. Predictors of overall and disease-free survival in metastatic castration-resistant prostate cancer patients receiving 225Ac-PSMA-617 radioligand therapy. J Nucl Med. 2020;61:62\u20139.","journal-title":"J Nucl Med"},{"key":"7474_CR25","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.7150\/thno.94521","volume":"15","author":"J Zhang","year":"2025","unstructured":"Zhang J, Greifenstein L, Jakobsson V, et al. First-in-human study of an optimized, potential kit-type, SSTR antagonist 68Ga-DATA5m-LM4 in patients with metastatic neuroendocrine tumors. Theranostics. 2025;15:2510\u201322.","journal-title":"Theranostics"},{"key":"7474_CR26","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.2967\/jnumed.111.087999","volume":"52","author":"M Fani","year":"2011","unstructured":"Fani M, Del Pozzo L, Abiraj K, et al. PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference. J Nucl Med. 2011;52:1110\u20138.","journal-title":"J Nucl Med"},{"key":"7474_CR27","doi-asserted-by":"publisher","first-page":"102819","DOI":"10.1155\/2013\/102819","volume":"2013","author":"L Wang","year":"2013","unstructured":"Wang L, Tang K, Zhang Q, et al. Somatostatin receptor-based molecular imaging and therapy for neuroendocrine tumors. Biomed Res Int. 2013;2013:102819.","journal-title":"Biomed Res Int"},{"key":"7474_CR28","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2967\/jnumed.112.102764","volume":"53","author":"M Fani","year":"2012","unstructured":"Fani M, Braun F, Waser B, et al. Unexpected sensitivity of sst2 antagonists to N-terminal radiometal modifications. J Nucl Med. 2012;53:1481\u20139.","journal-title":"J Nucl Med"},{"key":"7474_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.802676","volume":"11","author":"J Huang","year":"2022","unstructured":"Huang J, Fu L, Hu K, et al. Automatic production and preliminary PET imaging of a new imaging agent [18F]AlF-FAPT. Front Oncol. 2022;11: 802676.","journal-title":"Front Oncol"},{"key":"7474_CR30","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00259-018-4193-y","volume":"46","author":"S Krebs","year":"2019","unstructured":"Krebs S, Pandit-Taskar N, Reidy D, et al. Biodistribution and radiation dose estimates for 68Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors. Eur J Nucl Med Mol Imaging. 2019;46:677\u201385.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7474_CR31","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000471879","volume":"105","author":"A Sundin","year":"2017","unstructured":"Sundin A, Arnold R, Baudin E, et al. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological, nuclear medicine & hybrid imaging. Neuroendocrinology. 2017;105:212\u201344.","journal-title":"Neuroendocrinology"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07474-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07474-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07474-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:43:15Z","timestamp":1769834595000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07474-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,30]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7474"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07474-x","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,30]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in accordance with the guidelines of the Institutional Animal Care and Use Committee of Nanfang Hospital, Southern Medical University (Approval No: IACUC-LAC-20231201-001). The human imaging study was approved by the Institutional Review Board of The First Affiliated Hospital of Guilin Medical University (Approval No: 2024IITLL-36) and registered at the Chinese Clinical Trial Registry (ChiCTR2400093287).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All the authors approved the publication of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Informed consents were obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or fnancial relationships that could be construed as a potential confict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}